Results for tag: "Cholestasis Drug"

Cholestasis is a condition in which bile flow from the liver is blocked, leading to a buildup of bile acids in the body. Liver and kidney disorders drugs are used to treat cholestasis and its associated symptoms. These drugs work by reducing the production of bile acids, increasing bile flow, and reducing inflammation. Commonly used drugs include ursodeoxycholic acid, rifampicin, and chenodeoxycholic acid. Other drugs, such as statins, may also be used to reduce the risk of complications associated with cholestasis. The cholestasis drug market is a rapidly growing segment of the global pharmaceutical industry. It is driven by the increasing prevalence of liver and kidney disorders, as well as the development of new drugs to treat these conditions. The market is expected to continue to grow in the coming years, as more drugs are developed and approved for use. Some of the major companies in the cholestasis drug market include AbbVie, Merck, Pfizer, Novartis, and Bristol-Myers Squibb. Show Less Read more